Net Sales up 12% to $128.3 Million, GAAP EPS up 30% to $0.30
Adjusted EBITDA up 42% to $15.2 Million
Raised Full-Year Outlook
Nature’s Sunshine Products, Inc. (Nasdaq: NATR) (“Nature’s Sunshine”), a leading manufacturer of high-quality herbal and nutritional supplements, reported financial results for the third quarter ended September 30, 2025.
Third Quarter 2025 Financial Summary vs. Same Year-Ago Quarter
Net sales were up 12% to $128.3 million compared to $114.6 million (up 10% in constant currency).
Gross profit margin increased 200 basis points to 73.3% compared to 71.3%.
GAAP net income attributable to common shareholders was $5.3 million, or $0.30 per diluted common share, compared to $4.3 million, or $0.23 per diluted common share.
Adjusted EBITDA was up 42% to $15.2 million compared to $10.7 million.
Management Commentary
“The momentum in our business continued to accelerate in the third quarter, with record net sales of $128 million and adjusted EBITDA of $15 million, representing year-over-year growth of 12% and 42%, respectively,”
said Shane Jones, CFO of Nature’s Sunshine.
“Our strategic investments in North America Digital continue to pay off, as a surge in new customers, coupled with strong retention, yielded a 52% year-over-year increase in Digital sales.
We also continue to see exceptional results in Asia-Pacific, driven by 30%+ growth in both Japan and China